Vertex Pharmaceuticals (VRTX): Rep. Lisa C. McClain (MI09) disclosed a sale $1K–$15K
Rep. Lisa C. McClain (MI09) disclosed a sale of Vertex Pharmaceuticals in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 63 days
- Disclosure lag
- Traded
- Jun 11, 2025
- Disclosed
- Aug 13, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Dec 11, 2024Congress · 1 personMembers of Congress: 2 purchases
- Mar 20, 2025Congress · 1 personMembers of Congress: 2 sales
- May 2, 2025InsiderDirector sold ~$202K of VRTX shares in the open market
- May 12, 2025CongressDisclosed sale of VRTX — reported range $15,001 - $50,000
- May 15, 2025InsiderOfficer sold ~$22K of VRTX shares in the open market
- May 22, 2025FDAFDA drug approval: Kalydeco
- May 22, 2025FDAFDA drug approval: Kalydeco
- Jun 10, 2025CongressDisclosed partial sale of VRTX — reported range $1,001 - $15,000
- Jun 11, 2025 · this disclosureCongressDisclosed sale of VRTX — reported range $1,001 - $15,000
What came next
- Jun 11, 2025CongressDisclosed sale of VRTX — reported range $1,001 - $15,000
- Aug 6, 2025Insider · 2 peopleInsiders: 4 purchases (~$5.8M)
- Aug 7, 2025CongressDisclosed purchase of VRTX — reported range $1,001 - $15,000
- Aug 27, 2025InsiderDirector sold ~$103K of VRTX shares in the open market
- Oct 2, 2025InsiderOfficer sold ~$281K of VRTX shares in the open market
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Vertex Pharmaceuticals
For Vertex Pharmaceuticals, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.
Other recent filings by Rep. Lisa C. McClain (MI09)
- House Clerk periodic transaction report at CACI (CACI)Oct 12, 2026
- House Clerk periodic transaction report at Caterpillar (CAT)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Immunitybio (IBRX)Oct 12, 2026
- House Clerk periodic transaction report at Microsoft (MSFT)Oct 12, 2026
The full history of Rep. Lisa C. McClain (MI09) is on the profile page.
How this filing works
Explore the data
Other disclosures at Vertex Pharmaceuticals
- SEC Form 144Nov 12, 2026
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 6, 2026
- House Clerk periodic transaction reportSep 5, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its VRTX page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data